Showing results (11-20 of 77) with videos related to
Sort By:
Pageof 8
Hormone Research|January 1, 1991
Urinary growth hormone excretion in 657 healthy children and adults: normal values, inter- and intraindividual variationsK Main, M Philips, M Jørgensen, et al.Annals of Internal Medicine|February 1, 1986
Circulating coagulation inhibitors in the acquired immunodeficiency syndromeA J Cohen, T M Philips, C M KesslerBiochimica Et Biophysica Acta|April 12, 1978
Yeast 3-phosphoglycerate kinase. Essential arginyl residues at the 3-phosphoglycerate binding siteM Philips, C Roustan, A Fattoum, et al.European Journal of Biochemistry|July 15, 1988
Kinetics of inhibition of tissue-type and urokinase-type plasminogen activator by plasminogen-activator inhibitor type 1 and type 2S Thorsen, M Philips, J Selmer, et al.Thrombosis and Haemostasis|October 28, 1987
Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasmaM Jørgensen, M Philips, S Thorsen, et al.Journal of Cutaneous Pathology|June 1, 1978
Melanoacanthoma. Ultrastructural and immunological studiesO L Schlappner, G Rowden, T M Philips, et al.Catheterization and Cardiovascular Diagnosis|January 1, 1982
Rapid assessment of ventricular function in acute volume overload using opaque myocardial markersW P Santamore, A A Bove, C M Philips, et al.Biomedical Instrumentation & Technology|December 1, 2000
A perfluorochemical loss/restoration (L/R) system for tidal liquid ventilationR Libros, C M Philips, M R Wolfson, et al.Clinical Nephrology|August 1, 1979
Malignant melanoma with renal dense deposits containing tumor antigensJ L Olson, T M Philips, M G Lewis, et al.Thrombosis and Haemostasis|November 10, 1992
A specific immunologic assay for functional plasminogen activator inhibitor 1 in plasma--standardized measurements of the inhibitor and related parameters in patients with venous thromboembolic diseaseM Philips, A G Juul, J Selmer, et al.Pageof 8